A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype

J Am Acad Dermatol. 2019 Apr;80(4):938-946. doi: 10.1016/j.jaad.2018.09.018. Epub 2018 Sep 20.

Abstract

Background: Differences in relative survival (RS) of melanoma between histologic subtypes were discussed to be mainly caused by tumor thickness.

Objective: To investigate RS of melanoma, stratified by tumor thickness for each histologic subtype, and identify survival trends.

Methods: With use of cancer registry data on melanoma cases (International Classification of Diseases, 10th Revision, codes C43.0-C43.9) diagnosed in Germany in 1997-2013, 5- and 10-year age-standardized RS stratified by histologic subtype and stratified or standardized by T stage was estimated by standard and modeled period analyses. We restricted 10-year RS analyses to patients younger than 75 years.

Results: We analyzed 82,901 cases. Overall, the 5- and 10-year RS rates were 91.7% and 90.8%, respectively. Prognosis worsened with increasing T stage for all histologic subtypes, but T-stage distribution varied substantially. Survival differences by histologic subtype were strongly alleviated after adjustment for T stage but remained significant. Overall, 5-year RS increased significantly (by 3.8 percentage points) between the periods 2002-2005 and 2010-2013. This increase was no longer seen after adjustment for T stage.

Limitations: Exclusion of cases on account of missing information on T stages, changes in the definition of T stages, and lack of information on screening and treatment limit our analyses.

Conclusion: Differences in RS between histologic subtypes were strongly mediated by tumor thickness. Over time, RS of melanoma increased as a result of changes in T-stage distribution.

Keywords: T stage; histologic subtype; histology; melanoma; prognosis; prognostic factor; relative survival; stage; trend; tumor thickness.

MeSH terms

  • Aged
  • Female
  • Germany / epidemiology
  • Humans
  • Male
  • Melanoma / mortality*
  • Melanoma / pathology
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Registries*
  • Skin Neoplasms / mortality*
  • Skin Neoplasms / pathology
  • Survival Analysis